Medical devices, healthcare technology and the business of care
510(k) clearance · K252139

Kentrospine Viktr-MIS Pedicle screw system

Rivarp Medical Pvt., Ltd. · Decision date Sep 27, 2026

MEDTECHLEDGER EXPLANATIONK252139

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for K252139, the Kentrospine Viktr-MIS® Pedicle screw system, submitted by Rivarp Medical Pvt., Ltd. The decision date is 2026-09-27, with the device listed under regulation number 888.307023, medical specialty Orthopedic, and product code NKB. In 510(k) terms, SESE denotes clearance of the submission as substantially equivalent to a predicate; it is not a PMA approval.

The source material identifies the submission only as a premarket notification for the named pedicle screw system. It does not describe the specific components, sizes, materials, or any changed item relative to a predicate, and no predicate device is identified in the available text. The review memorandum and clearance letter, which would carry those details and any labeled indications, are not part of the supplied data, so the scope of the clearance beyond the named device remains unknown.

Readers should treat this as a dated regulatory record rather than evidence of clinical performance. No safety, effectiveness, or labeling conclusions are supported by the available fields, and the absence of the underlying documents limits any interpretation of what exactly was cleared.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 27, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K252139
Regulatory pathway
510(k) premarket notification
Product code
NKB
Decision code
SESE
Decision date
Sep 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Product code
NKB
FDA device class
2

FDA decision timeline

  1. K252139 received

    Application receipt date recorded by FDA.

  2. K252139 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
SeaSpine Orthopedics Corporation510(k) clearanceOct 29, 2026FDA
GS Medical Co., Ltd.510(k) clearanceOct 2, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rivarp Medical Pvt., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Bangalore

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records